University of Virginia
Charlottesville, Virginia
Public University
Founded 1819
UVA is a leading public research university with strong commercialization in biomedical sciences, data science, and engineering.
$813.8M
R&D (FY2024)
62
US Patents (2025)
$34.2M
Business-Funded R&D
Research and Commercialization Data
Total R&D Expenditures
5-Year Change: 24.8%
Avg: 690.9
- Research spending (FY2024): $813.8M total, of which $34.2M was funded by business. NSF National Center for Science and Engineering Statistics NSF reporting unit: U. Virginia, Charlottesville.
- US patents granted (2025): 62 (rank #38). National Academy of Inventors
- UVA does not publish annual tech transfer figures (disclosures, licenses, startups, licensing revenue) that we could find.
Research Focus Areas
Biomedical Sciences
Cancer, cardiovascular, and infectious disease
School of Medicine
Data Science
Machine learning and data systems
School of Data Science
Engineering
Systems, materials, and biomedical engineering
School of Engineering and Applied Science
Related Market Maps
Explore market opportunities in deep tech categories relevant to UVA's research focus.
Biotechnology
13.96% CAGRApplication of biological systems and organisms to develop products and technologies
Market Size$1.55T
Neurotechnology
13% CAGRTechnologies interfacing with the nervous system for medical and research applications
Market Size$17.3B
Robotics & Automation
15% CAGRAutomated systems and robots for industrial and commercial applications
Market Size$90.2B
Advanced Manufacturing
12.1% CAGRNext-generation manufacturing technologies and processes
Market Size$410.7B
Notable Spinouts
Programs & Resources
Tech Transfer Office
UVA Licensing & Ventures Group (LVG)
Services Offered
- •IP management
- •Licensing
- •Startup support
- •Industry partnerships
Interested in Tech Transfer?
Learn how to navigate university licensing and commercialization